Peinado, Paola https://orcid.org/0000-0003-2484-928X
Stazi, Marco https://orcid.org/0000-0002-8193-1610
Ballabio, Claudio https://orcid.org/0000-0001-6632-1489
Margineanu, Michael-Bogdan
Li, Zhaoqi
Colón, Caterina I.
Hsieh, Min-Shu
Pal Choudhuri, Shreoshi https://orcid.org/0000-0003-1600-7664
Stastny, Victor
Hamilton, Seth https://orcid.org/0009-0008-3841-7799
Le Marois, Alix https://orcid.org/0000-0003-4464-4089
Collingridge, Jodie https://orcid.org/0000-0002-0952-6151
Conrad, Linus
Chen, Yinxing
Ng, Sheng Rong https://orcid.org/0000-0003-1655-2443
Magendantz, Margaret
Bhutkar, Arjun
Chen, Jin-Shing
Sahai, Erik https://orcid.org/0000-0002-3932-5086
Drapkin, Benjamin J. https://orcid.org/0000-0002-4824-7243
Jacks, Tyler https://orcid.org/0000-0001-5785-8911
Vander Heiden, Matthew G. https://orcid.org/0000-0002-6702-4192
Kopanitsa, Maksym V.
Robinson, Hugh P. C. https://orcid.org/0000-0002-5048-9954
Li, Leanne https://orcid.org/0000-0002-1598-1564
Article History
Received: 25 October 2023
Accepted: 23 December 2024
First Online: 12 February 2025
Competing interests
: Z.L. is currently an employee of Sesame Therapeutics and shareholder of Sesame Therapeutics and Tango Therapeutics. L.C. is currently an employee of AstraZeneca. B.J.D. consults for AstraZeneca, Sonata Therapeutics and Dialectic Therapeutics. J.-S.C. receives research funding from VolitionRX and AstraZeneca (Taiwan). M.G.V.H. discloses that he is a scientific advisor for Sage Therapeutics, Agios Pharmaceuticals, Auron Therapeutics, iTeos Therapeutics, Lime Therapeutics, Pretzel Therapeutics, MPM Capital and Droia Ventures. T.J. is a member of the Board of Directors of Amgen and Thermo Fisher Scientific. He is also a co-founder of Dragonfly Therapeutics and T2 Biosystems. T.J. serves on the Scientific Advisory Board of Dragonfly Therapeutics, SQZ Biotech and Skyhawk Therapeutics. None of these affiliations represent a conflict of interest with respect to the design or execution of this study or the interpretation of the data presented in this paper.